Molina Healthcare stock is trading -19.73% below its average target price of $353.52 after dropping -10.5% during today's afternoon session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $309.0 to $406.0 per share.
The stock has an average amount of shares sold short at 2.3%, and a short ratio of 2.22. The company's insiders own 1.13% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 99.6% of Molina Healthcare's shares being owned by this investor type.
Institutions Invested in Molina Healthcare
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | Vanguard Group Inc | 12% | 6,664,371 | $1,891,248,548 |
| 2024-09-30 | Capital World Investors | 9% | 5,130,339 | $1,455,913,271 |
| 2024-09-30 | Blackrock Inc. | 9% | 5,126,528 | $1,454,831,767 |
| 2024-09-30 | Price (T.Rowe) Associates Inc | 7% | 3,939,288 | $1,117,910,859 |
| 2024-09-30 | Capital Research Global Investors | 6% | 3,490,747 | $990,621,650 |
| 2024-09-30 | State Street Corporation | 5% | 2,614,311 | $741,902,256 |
| 2024-09-30 | Wellington Management Group, LLP | 4% | 2,451,159 | $695,602,165 |
| 2024-09-30 | T. Rowe Price Investment Management, Inc. | 4% | 2,009,584 | $570,289,802 |
| 2024-09-30 | Capital International Investors | 3% | 1,714,726 | $486,613,524 |
| 2024-09-30 | Geode Capital Management, LLC | 2% | 1,401,917 | $397,843,020 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Molina Healthcare.
